SEC Form 4 · accession 0001127602-19-006129
VARIAN MEDICAL SYSTEMS INC · VAR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kolleen T Kennedy
Officer — EVP and Pres. Oncology Sys.
Period of report
Feb 12, 2019
Accepted (ET)
Feb 14, 2019 · 7:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000203527
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 12, 2019 | M | 419 | $67.12 | A | 27,317 | D | |
| Common StockF2 | Feb 12, 2019 | S | 419 | $132.117 | D | 26,898 | D | |
| Common Stock | Feb 12, 2019 | M | 669 | $67.12 | A | 27,567 | D | |
| Common StockF3 | Feb 12, 2019 | S | 669 | $132.8489 | D | 26,898 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Qualified Stock Option (Right to Buy)F4 | $67.12 | Feb 12, 2019 | M | 419 | D | — | Feb 12, 2023 | Common Stock | 419 | 669 | D |
| Non Qualified Stock Option (Right to Buy)F4 | $67.12 | Feb 12, 2019 | M | 669 | D | — | Feb 12, 2023 | Common Stock | 669 | 0 | D |
Explanation of responses
- F1This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan
- F2The 419 shares were sold in multiple transactions executed on the same day at prices ranging from $131.61 to $132.58. The detailed breakdown of executed sales will be furnished upon request
- F3The 669 shares were sold in multiple transactions executed on the same day at prices ranging from $132.62 to $132.97. The detailed breakdown of executed sales will be furnished upon request
- F4Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.